85 related articles for article (PubMed ID: 5924281)
1. Suppression of activity of the adrenal cortex by dexamethasone in Cushing's syndrome.
Cassidy CE; Rosenfeld PS; Bokat MA
J Clin Endocrinol Metab; 1966 Nov; 26(11):1181-4. PubMed ID: 5924281
[No Abstract] [Full Text] [Related]
2. Cushing's disease: megadose dexamethasone suppression in a case refractory to medical therapy.
Warren SE; Westbie DK; Daly R; Bower RH
South Med J; 1979 Apr; 72(4):412-4. PubMed ID: 219547
[TBL] [Abstract][Full Text] [Related]
3. Pituitary-adrenocortical studies in a patient with Cushing's syndrome induced by thymoma.
Miura K; Sasaki C; Katsushima I; Ohtomo T; Sato S; Demura H; Torikai T; Sasano N
J Clin Endocrinol Metab; 1967 May; 27(5):631-7. PubMed ID: 4290580
[No Abstract] [Full Text] [Related]
4. Overnight suppression test with dexamethasone in Cushing's syndrome.
Sawin CT; Bray GA; Idelson BA
J Clin Endocrinol Metab; 1968 Mar; 28(3):422-4. PubMed ID: 4868264
[No Abstract] [Full Text] [Related]
5. [Paradoxical response of adrenal glands to dexamethasone in a case of adrenal carcinoma].
Medizinische Poliklinik der Universität Würzburg
MMW Munch Med Wochenschr; 1975 May; 117(22):955-6. PubMed ID: 168485
[No Abstract] [Full Text] [Related]
6. [A case of Cushing's disease with paradoxical response to dexamethasone].
Kubo M; Nakagawa K; Akikawa K; Matsubara M; Ishizuka T; Nakagawa S
Nihon Naika Gakkai Zasshi; 1986 Jan; 75(1):75-82. PubMed ID: 3009668
[No Abstract] [Full Text] [Related]
7. Intermittent Cushing's syndrome with anomalous response to dexamethasone.
Brooks RV; Jeffcoate SL; London DR; Prunty FT; Smith PM
J Endocrinol; 1966 Sep; 36(1):53-61. PubMed ID: 4288409
[No Abstract] [Full Text] [Related]
8. Cushing's syndrome. An evaluation of the clinical usefulness of urinary free cortisol and other urinary steroid measurements in diagnosis.
Burke CW; Beardwell CG
Q J Med; 1973 Jan; 42(165):175-204. PubMed ID: 4688791
[No Abstract] [Full Text] [Related]
9. [Investigation of Cushing's syndrome. The diagnostic value of the dexamethasone suppression test, the metopirone test and the CRF test].
Johannesen O; Jørgensen H; Frey H; Norman N
Tidsskr Nor Laegeforen; 1989 Sep; 109(26):2678-82. PubMed ID: 2554527
[TBL] [Abstract][Full Text] [Related]
10. Reliability and significance of the dexamethasone suppression test in Cushing's disease.
N Engl J Med; 1967 Aug; 277(8):431. PubMed ID: 4378315
[No Abstract] [Full Text] [Related]
11. Diagnostic tests for children who are referred for the investigation of Cushing syndrome.
Batista DL; Riar J; Keil M; Stratakis CA
Pediatrics; 2007 Sep; 120(3):e575-86. PubMed ID: 17698579
[TBL] [Abstract][Full Text] [Related]
12. Suppression of ACTH by cortisol in dexamethasone-nonsuppressible Cushing's disease.
Carey RM
N Engl J Med; 1980 Jan; 302(5):275-9. PubMed ID: 6243171
[No Abstract] [Full Text] [Related]
13. [The diagnosis of Cushing's syndrome. Results of diagnostic assessment of 20 patients with Cushing's syndrome of variable etiology (1979-1989)].
Caduff F; Staub JJ; Nordmann A; Radü EW; Landolt H
Schweiz Med Wochenschr; 1991 Jan; 121(1-2):10-20. PubMed ID: 1990418
[TBL] [Abstract][Full Text] [Related]
14. Biochemical assessment of Cushing's disease in patients with corticotroph macroadenomas.
Katznelson L; Bogan JS; Trob JR; Schoenfeld DA; Hedley-Whyte ET; Hsu DW; Zervas NT; Swearingen B; Sleeper M; Klibanski A
J Clin Endocrinol Metab; 1998 May; 83(5):1619-23. PubMed ID: 9589666
[TBL] [Abstract][Full Text] [Related]
15. Cushing's syndrome with fluctuation due to adrenal adenoma.
Green JR; van't Hoff W
J Clin Endocrinol Metab; 1975 Aug; 41(2):235-40. PubMed ID: 1159041
[TBL] [Abstract][Full Text] [Related]
16. Implantation of the sella turcica with 90-yttrium in the treatment of Cushing's syndrome of pituitary origin.
Molinatti GM; Camanni F; Massara F; Messina M
J Clin Endocrinol Metab; 1967 Jun; 27(6):861-76. PubMed ID: 6026365
[No Abstract] [Full Text] [Related]
17. Cushing's syndrome caused by a metyrapone responsive adrenocortical adenoma.
Crystal RG; Rose LI; Jagger PI; Lauler DP
J Clin Endocrinol Metab; 1970 Aug; 31(2):199-203. PubMed ID: 4317343
[No Abstract] [Full Text] [Related]
18. Transition from pituitary-dependent to adrenal-dependent Cushing's syndrome.
Hermus AR; Pieters GF; Smals AG; Pesman GJ; Lamberts SW; Benraad TJ; van Haelst UJ; Kloppenborg PW
N Engl J Med; 1988 Apr; 318(15):966-70. PubMed ID: 2832758
[No Abstract] [Full Text] [Related]
19. Familial adrenocorticotropin-independent Cushing's syndrome with bilateral macronodular adrenal hyperplasia.
Findlay JC; Sheeler LR; Engeland WC; Aron DC
J Clin Endocrinol Metab; 1993 Jan; 76(1):189-91. PubMed ID: 8380604
[TBL] [Abstract][Full Text] [Related]
20. The low-dose dexamethasone suppression test: a reevaluation in patients with Cushing's syndrome.
Findling JW; Raff H; Aron DC
J Clin Endocrinol Metab; 2004 Mar; 89(3):1222-6. PubMed ID: 15001614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
